410 related articles for article (PubMed ID: 17515460)
21. [Evaluation of ischemic preconditioning on collateral circulation, ventricular function and clinical outcome in acute myocardial infarction].
Antelmi I; Kalil R; Lopes NH; Forlenza LM; Barduco MS; Piva de Albuquerque C; Tranchesi B; Bellotti G; Pileggi F
Arq Bras Cardiol; 1996 Jan; 66(1):11-4. PubMed ID: 8731317
[TBL] [Abstract][Full Text] [Related]
22. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
French CJ; Zaman AK; Sobel BE
Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing.
Beohar N; Flaherty JD; Davidson CJ; Vidovich M; Singhal S; Rapp JA; Erdogan A; Lee DC; Rammohan C; Brodsky A; Wu E; Pieper K; Virmani R; Bonow RO; Mehta J
Catheter Cardiovasc Interv; 2007 Feb; 69(2):257-66. PubMed ID: 17253607
[TBL] [Abstract][Full Text] [Related]
24. Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.
Jacquier A; Boussel L; Amabile N; Bartoli JM; Douek P; Moulin G; Paganelli F; Saeed M; Revel D; Croisille P
Invest Radiol; 2008 Nov; 43(11):773-81. PubMed ID: 18923256
[TBL] [Abstract][Full Text] [Related]
25. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
[TBL] [Abstract][Full Text] [Related]
26. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
27. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
[TBL] [Abstract][Full Text] [Related]
28. Area at risk and viability after myocardial ischemia and reperfusion can be determined by contrast-enhanced cardiac magnetic resonance imaging.
Vosseler M; Abegunewardene N; Hoffmann N; Petersen SE; Becker D; Cleppien D; Kunz P; Kreitner KF; Lauterbach M; Bierbach B; Düber C; Gori T; Munzel T; Schreiber LM; Horstick G
Eur Surg Res; 2009; 43(1):13-23. PubMed ID: 19365131
[TBL] [Abstract][Full Text] [Related]
29. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging.
Ripa RS; Nilsson JC; Wang Y; Søndergaard L; Jørgensen E; Kastrup J
Am Heart J; 2007 Nov; 154(5):929-36. PubMed ID: 17967600
[TBL] [Abstract][Full Text] [Related]
30. Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.
Omerovic E; Bollano E; Mobini R; Madhu B; Kujacic V; Soussi B; Hjalmarson A; Waagstein F
Biochem Biophys Res Commun; 2001 Feb; 281(2):491-8. PubMed ID: 11181074
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
32. First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.
Su MY; Yang KC; Wu CC; Wu YW; Yu HY; Tseng RY; Tseng WY
J Cardiovasc Magn Reson; 2007; 9(4):633-44. PubMed ID: 17578718
[TBL] [Abstract][Full Text] [Related]
33. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol.
Cimmino G; Ibanez B; Giannarelli C; Prat-González S; Hutter R; Garcia M; Sanz J; Fuster V; Badimon JJ
Int J Cardiol; 2011 Dec; 153(3):256-61. PubMed ID: 20864196
[TBL] [Abstract][Full Text] [Related]
35. Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner.
Luo D; Yao YY; Li YF; Sheng ZL; Tang Y; Fang F; Fang K; Ma GS; Teng GJ
Cardiovasc Pathol; 2012; 21(2):112-9. PubMed ID: 21652224
[TBL] [Abstract][Full Text] [Related]
36. Chronic ischemic mitral regurgitation induced in pigs by catheter-based coronary artery occlusion.
Bjerre M; Jensen H; Andersen JD; Ringgaard S; Smerup M; Wierup P; Hasenkam JM; Nielsen SL
J Heart Valve Dis; 2008 May; 17(3):283-9. PubMed ID: 18592925
[TBL] [Abstract][Full Text] [Related]
37. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).
Pizarro G; Fernández-Friera L; Fuster V; Fernández-Jiménez R; García-Ruiz JM; García-Álvarez A; Mateos A; Barreiro MV; Escalera N; Rodriguez MD; de Miguel A; García-Lunar I; Parra-Fuertes JJ; Sánchez-González J; Pardillos L; Nieto B; Jiménez A; Abejón R; Bastante T; Martínez de Vega V; Cabrera JA; López-Melgar B; Guzman G; García-Prieto J; Mirelis JG; Zamorano JL; Albarrán A; Goicolea J; Escaned J; Pocock S; Iñiguez A; Fernández-Ortiz A; Sánchez-Brunete V; Macaya C; Ibanez B
J Am Coll Cardiol; 2014 Jun; 63(22):2356-62. PubMed ID: 24694530
[TBL] [Abstract][Full Text] [Related]
38. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.
Ndrepepa G; Mehilli J; Martinoff S; Schwaiger M; Schömig A; Kastrati A
J Am Coll Cardiol; 2007 Jul; 50(2):149-56. PubMed ID: 17616299
[TBL] [Abstract][Full Text] [Related]
39. Influence of an early adrenergic blockade on thrombotic infarct size and myocardial metabolism.
Zmudka K; Dubiel J; Pieniazek P; Dudek D; Kocurek A; Trebacz J; Grodecki J; Flameng W; de Geest H
J Physiol Pharmacol; 1998 Sep; 49(3):333-52. PubMed ID: 9789788
[TBL] [Abstract][Full Text] [Related]
40. Endocardial electromechanical mapping in a porcine acute infarct and reperfusion model evaluating the extent of myocardial ischemia.
Odenstedt J; Månsson C; Jansson SO; Grip L
J Invasive Cardiol; 2003 Sep; 15(9):497-501. PubMed ID: 12947209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
